Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1274 studies found for:    "age-related macular degeneration"
Show Display Options
Rank Status Study
1 Unknown  Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population
Condition: Age-Related Macular Degeneration
Intervention: Procedure: drawing blood
2 Active, not recruiting Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
Condition: Age Related Macular Degeneration
Intervention: Drug: 3 dose cohorts gene therapy
3 Completed WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination
Condition: Age Related Macular Degeneration
Interventions: Drug: AL-39324 ophthalmic suspension;   Drug: Ranibizumab 10 mg/mL
4 Recruiting Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal
Condition: Age-Related Macular Degeneration
Intervention:
5 Unknown  Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention:
6 Active, not recruiting Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)
Condition: Age-related Macular Degeneration
Interventions: Drug: Omega-3 fatty acids (fish oil);   Dietary Supplement: Vitamin D3;   Dietary Supplement: Vitamin D3 placebo;   Dietary Supplement: Fish oil placebo
7 Recruiting Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections
Condition: Age Related Macular Degeneration
Intervention: Drug: Aflibercept
8 Unknown  A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Drug: DE-120
9 Active, not recruiting A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: DE-120;   Drug: Aflibercept
10 Terminated A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
Condition: Wet Age-related Macular Degeneration
Intervention:
11 Recruiting A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Drug: DE-122
12 Completed
Has Results
A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.
Condition: Exudative Age-related Macular Degeneration
Intervention: Drug: Macugen
13 Recruiting Study of Dark Adaptation in Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention:
14 Unknown  Intravitreal Bevacizumab for Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: bevacizumab intravitreal injection
15 Suspended Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration
Condition: Dry Age Related Macular Degeneration
Intervention: Drug: Copaxone Injection
16 Completed
Has Results
Improving Function in Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Behavioral: PST;   Behavioral: ST
17 Completed Investigating Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention:
18 Recruiting Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration
Condition: Neovascular Age-related Macular Degeneration
Intervention: Biological: TK001
19 Active, not recruiting Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy
Condition: Age-related Macular Degeneration
Intervention:
20 Unknown  Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.